In addition, anti-EpCAM CAR-T cells demonstrated significant anti-tumor activity against CSCs of EpCAM solid tumors (e.g., colon cancer, breast cancer, etc.)without significant systemic toxicities (158). This evidence concerns the gene EPCAM and malignant colon neoplasm.